Finance

Lists
Why is 002393 up 2.26%?
Dive Deeper
002393:SHE
Tianjin Lisheng Pharmaceutical Co Ltd
CNÂ¥13.13
+2.26%
(+0.29) 1D
Nov 4, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002393...
Open
CNÂ¥12.92
High
CNÂ¥13.66
Low
CNÂ¥12.84
Mkt. cap
3.96B
Avg. vol.
1.93M
Volume
6.14M
Dividend
5.71%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Apr 28, 2026
P/E ratio
32.95
52-wk high
CNÂ¥20.35
52-wk low
CNÂ¥12.32
EPS
CNÂ¥0.40
Shares outstanding
308.29M
No. of employees
2K
Open
CNÂ¥12.92
High
CNÂ¥13.66
Low
CNÂ¥12.84
Mkt. cap
3.96B
Avg. vol.
1.93M
Volume
6.14M
Dividend
5.71%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Apr 28, 2026
P/E ratio
32.95
52-wk high
CNÂ¥20.35
52-wk low
CNÂ¥12.32
EPS
CNÂ¥0.40
Shares outstanding
308.29M
No. of employees
2K
News stories
From web sources and news partners
About Tianjin Lisheng Pharmaceutical Co Ltd
CEO-
Employees1.6K
Founded1951
Headquarters-
SectorPharmaceutical industry
Industry-
Websitelishengpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
384.73M
332.28M
309.35M
246.38M
Cost of goods sold
220.06M
148.48M
153.50M
127.44M
Cost of revenue
220.06M
148.48M
153.50M
127.44M
Research and development expenses
22.62M
19.98M
19.32M
17.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
135.01M
108.37M
109.40M
83.36M
Operating expense
165.03M
132.42M
134.21M
101.49M
Total operating expenses
385.09M
280.90M
287.72M
228.92M
Operating income
-356.56K
51.38M
21.63M
17.46M
Other non operating income
13.61M
-7.05K
-353.00K
-2.27M
EBT including unusual items
22.59M
62.31M
32.70M
1.93M
EBT excluding unusual items
20.55M
61.02M
30.55M
18.46M
Income tax expense
-25.85M
9.24M
5.69M
50.31K
Effective tax rate
-114.43%
14.83%
17.41%
2.60%
Other operating expenses
7.49M
4.08M
5.42M
502.25K
Net income
45.54M
51.88M
26.44M
183.95K
Net profit margin
11.84%
15.61%
8.55%
0.07%
Earnings per share
-
-
-
-
Interest and investment income
7.66M
10.11M
9.61M
3.29M
Interest expense
-342.54K
-456.05K
-360.99K
-
Net interest expenses
7.31M
9.65M
9.25M
3.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
18.04M
69.77M
39.25M
35.85M
Gain or loss from assets sale
-249.61K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps